Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GDTC
INAB
Add up to 3 more stocks
GDTC
CytoMed Therapeutics Limited
-9.88%
$0.91-0.10Delayed quote: Oct 6, 2026, 12:01 PM EDT
Market Cap
$10.77M
52W Range
$0.68 - $3.68
INAB
IN8bio, Inc.
+0.70%
$1.43+0.01Delayed quote: Oct 6, 2026, 11:52 AM EDT
Market Cap
$13.71M
52W Range
$0.88 - $2.73
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.81 | 0.75 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | N/A | 0.0% |
| Operating Margin | N/A | 0.0% |
| Net Margin | N/A | 0.0% |
| ROE | N/A | -101.7% |
| ROA | N/A | -85.8% |
| ROIC | N/A | -91.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.64 | 8.21 |
| Quick Ratio | 2.64 | 8.21 |
| Debt/Equity | 0.09 | 0.12 |
| Interest Coverage | -219.72 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.